Ionis Pharmaceuticals, Inc. (IONS) vs TG Therapeutics, Inc. (TGTX)
- Ionis Pharmaceuticals, Inc. IONS 42.94 −2.67%
- TG Therapeutics, Inc. TGTX 53.97 −3.63%
Ionis Pharmaceuticals, Inc. and TG Therapeutics, Inc. are both Biotechnology companies. TG Therapeutics, Inc. is the larger, with a market value of $8.6B against $7.3B — 1.2× the size. Ionis Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; TG Therapeutics, Inc. trades at 17.8×. TG Therapeutics, Inc. grew revenue faster over the last twelve months: 76.1% against −7.41%. TG Therapeutics, Inc. has the higher net margin (55.2% vs −64.7%) and the higher return on invested capital (10.7% vs 0.00%). Across the 18 metrics below, TG Therapeutics, Inc. leads on 14 and Ionis Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | IONS | TGTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.17% | 82.37% | 65.16% |
| Operating margin | (68.00%) | 17.05% | 0.00% |
| Net margin | (64.66%) | 55.22% | 0.00% |
| Free cash flow margin | (64.93%) | 2.17% | 0.00% |
| Return on equity | (105.50%) | 100.28% | (56.36%) |
| Return on assets | (18.90%) | 37.70% | (48.04%) |
| Return on invested capital | 0.00% | 10.69% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack